The Tol/Pal system is a group of complex proteins found in Gram-negative bacteria that has a crucial function in bacterial outer membrane development and safety. It is a promising target for potential antibacterial therapy. Initially, this Tol/Pal system was thought to be associated with the uptake of toxins such as colicins by Escherichia coli. However, the latest research has revealed that this system has much broader features beyond that. The system has been extensively studied, and this article discusses some of the conclusions drawn from those studies. Most significantly, the Tol/Pal system is a prerequisite for the pathogenicity of many Gram-negative bacteria, indicating that it has a remarkable role in how these bacteria cause diseases. Moreover, this system plays a vital role in the growth and overall fitness of specific pathogens. This indicates that it may be a promising target for growing antimicrobial therapies. Significantly, one of the proteins in this system, called Pal, is highly recognizable through the immune system and may trigger each of the adaptive and innate immune responses. A lot of these features make the Tol/Pal system an exciting area of research for the development of antibacterial therapies, in particular for dealing with stubborn infections caused by gram-negative pathogens, which are resistant to a couple of drugs. This paper offers an outline of the mechanisms of the Tol/ Pal system within the context of bacterial disease development and its potential utilization as a vaccine to counter respective bacterial infections.